|
491
|
|
|
Solute carrier family 25 member 15 |
D13S327, HHH, LNC-HC, ORC1, ORNT1 |
Apraxia, Blood coagulation disorders, Cerebellar ataxia, Cerebral cortical atrophy, Chorioretinal atrophy, Developmental delay, Encephalopathy, Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Impaired cognition, Liver failure, Mental retardation, Myoclonic seizures, Spastic paraplegia, Specific learning disorder |
|
492
|
|
|
SWI/SNF complex antagonist associated with prostate cancer 1 |
LINC00913, PCAT11, PCAT114 |
|
|
493
|
|
|
- |
- |
|
|
494
|
|
|
Cyclin dependent kinase 2 |
CDKN2, p33(CDK2) |
|
|
495
|
|
|
RNA terminal phosphate cyclase like 1 |
RNAC, RPCL1 |
|
|
496
|
|
|
SPECC1L-ADORA2A readthrough (NMD candidate) |
- |
|
|
497
|
|
|
STAG3 cohesin complex component like 5, pseudogene |
- |
|
|
498
|
|
|
STAG3L5P-PVRIG2P-PILRB readthrough |
FDFACT, LOC101735302-LOC101752334-PILRB, PILRB |
|
|
499
|
|
|
Teneurin transmembrane protein 1 |
ODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1, ten-1 |
|
|
500
|
|
|
RNA binding motif protein 7 |
- |
|